Composition
- Active ingredients
- IPRATROPIUM BROMIDE 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- IPRATROPIUM BROMIDE 0.02% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionNDA020228-001 · Discontinued
- IPRATROPIUM BROMIDE 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Spray, meteredNDA020394-001 · Discontinued
- IPRATROPIUM BROMIDE 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Spray, meteredThis page
- IPRATROPIUM BROMIDE 0.018MG/INH · Aerosol, meteredNDA019085-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020393.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Atrovent
- Active substance
- ipratropium bromide
- Route
- Nasal
- Dosage form
- Spray, metered
- Applicant
- Boehringer Ingelheim
- Status
- Discontinued
- FDA approval
- 20 Oct 1995
- Application
- NDA020393-001